about
STAT1 pathway mediates amplification of metastatic potential and resistance to therapyOral PEG 15-20 protects the intestine against radiation: role of lipid rafts.Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumorsEfficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.Tumor endothelial inflammation predicts clinical outcome in diverse human cancersTranscriptional control of viral gene therapy by cisplatinSimvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression.Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.A manganese superoxide dismutase (SOD2)-mediated adaptive response.A survivin-associated adaptive response in radiation therapy.Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers.Characterization of response to radiation mediated gene therapy by means of multimodality imaging.STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.Glioblastoma cells block radiation-induced programmed cell death of endothelial cells.Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cellsEndothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.Tumor production of angiostatin is enhanced after exposure to TNF-alpha.Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation.Host STING-dependent MDSC mobilization drives extrinsic radiation resistance.Establishment of a syngeneic model of hepatic colorectal oligometastases.Angiostatin potentiates cyclophosphamide treatment of metastatic disease.Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy
P50
Q33463332-70D83877-DE74-4808-985B-6066329425E6Q33771730-A5AB270F-0BF9-4812-9C1D-E01E7BEB16E0Q34031756-5E5089A2-A9D0-4FFB-AAE7-2C405492F3D4Q34192330-B7A5033D-DAA6-4C6E-8699-21CA84583AA4Q34441112-B1B25098-D66A-4AFB-A18B-9C7514B112C7Q34795177-44B21F58-ED02-44D7-96A2-C0BCA5FE91B7Q34985466-57ECF082-9E00-4134-BA69-C1D9DED64B96Q34992789-7230691A-EE4A-430A-9E9B-DD2B029EC23BQ35119267-125FE285-D766-4C3A-9FD5-9C10921A2C4EQ35651491-A9A84F9C-E173-428D-9730-B415727B5EBFQ35939457-69DB2B89-A60C-436D-8F03-BDD96BC027CFQ36675861-7A9C3EF4-6E09-4195-AEEB-5722450745D8Q37040414-15430B8A-751C-42C8-8822-E8AE15DBBD75Q37376168-C8F3C392-C5C9-4674-8BC2-7DF3C23419DDQ37445965-1F189370-3BB6-422C-B773-36206A5C25B8Q37502349-052DA95E-9DC1-43C5-AD40-356E28A47E07Q38341425-8C011F32-BBEE-4884-8E24-011C82E0D337Q39403470-BABF6070-9AE7-4F8A-B5C3-E790F1C8F3F6Q40073614-E77A5180-58B3-4A09-A14E-634CF0086CF1Q40515731-922912E3-10ED-4152-B2F9-4F8B3ECFCC1BQ40744668-27A374D9-BFD4-4095-B5E9-EE4AB31AAA9CQ41309983-EEDA1E36-CB01-4ABA-825F-01BF5F141A60Q42456352-BAA27CAB-62BA-4177-9A40-E88584F13039Q43166847-1A0EACDF-46B6-4F47-9085-4BD6E596915BQ43790749-6ABB73FF-45AA-4419-9D5B-DD17E008CB30Q43997387-2F071F3D-7548-4F9A-BDFB-79F2756B1043Q45858536-A5BB4616-A8EF-4272-A340-E304CB74EB01Q45886797-964099E7-E96F-4EDF-ABD3-B026ED7E96CAQ46484924-8B2B5C89-7F42-44FC-BE9A-13362E5661DEQ47655012-9B371930-F7B7-4D2B-BB04-645542EA1A01Q48245206-6D21A1E4-CD0A-4AA4-9B0D-169F76529B9AQ53590033-F60D08C6-2E71-4617-81D0-C80D0FC3A0B0Q53662720-F3C44D12-2F71-43F5-B4ED-DFC050375567Q55473006-AA5BC148-176F-4F92-9C89-80FB24BCA2A6Q78835010-05CDD6BA-65CB-4353-84E1-470F2552B920
P50
name
Helena J Mauceri
@en
type
label
Helena J Mauceri
@en
prefLabel
Helena J Mauceri
@en